136 related articles for article (PubMed ID: 12446957)
41. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.
Courjal F; Cuny M; Simony-Lafontaine J; Louason G; Speiser P; Zeillinger R; Rodriguez C; Theillet C
Cancer Res; 1997 Oct; 57(19):4360-7. PubMed ID: 9331099
[TBL] [Abstract][Full Text] [Related]
42. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
43. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization.
Nishizaki T; DeVries S; Chew K; Goodson WH; Ljung BM; Thor A; Waldman FM
Genes Chromosomes Cancer; 1997 Aug; 19(4):267-72. PubMed ID: 9258662
[TBL] [Abstract][Full Text] [Related]
44. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
45. Prognostic features in patients with stage T1 breast carcinoma and a 0.5-cm or less lymph node metastasis. Significance of lymph node hilar tissue invasion.
Goldstein NS; Mani A; Vicini F; Ingold J
Am J Clin Pathol; 1999 Jan; 111(1):21-8. PubMed ID: 9894450
[TBL] [Abstract][Full Text] [Related]
46. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
Korn WM; Yasutake T; Kuo WL; Warren RS; Collins C; Tomita M; Gray J; Waldman FM
Genes Chromosomes Cancer; 1999 Jun; 25(2):82-90. PubMed ID: 10337990
[TBL] [Abstract][Full Text] [Related]
47. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Pinto AE; André S; Pereira T; Silva G; Soares J
Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
[TBL] [Abstract][Full Text] [Related]
48. Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.
Gao Y; Niu Y; Wang X; Wei L; Lu S
J Mol Med (Berl); 2009 Feb; 87(2):145-52. PubMed ID: 18936904
[TBL] [Abstract][Full Text] [Related]
49. Chromosomal genotype in breast cancer progression: comparison of primary and secondary manifestations.
Friedrich K; Weber T; Scheithauer J; Meyer W; Haroske G; Kunze KD; Baretton G
Cell Oncol; 2008; 30(1):39-50. PubMed ID: 18219109
[TBL] [Abstract][Full Text] [Related]
50. Identification of chromosomal changes with comparative genomic hybridization in sporadic breast cancer in Mexican women.
Valladares A; Salamanca F; Madrigal-Bujaidar E; Arenas D
Cancer Genet Cytogenet; 2004 Jul; 152(2):163-6. PubMed ID: 15262439
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of DNA ploidy in breast cancer stage I-II.
Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
[TBL] [Abstract][Full Text] [Related]
52. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
53. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
[TBL] [Abstract][Full Text] [Related]
54. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
55. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
56. Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma.
Keck B; Ellmann C; Stoehr R; Weigelt K; Goebell PJ; Kunath F; Taubert H; Hartmann A; Wullich B; Wach S
Urol Oncol; 2014 Nov; 32(8):1234-9. PubMed ID: 25087089
[TBL] [Abstract][Full Text] [Related]
57. Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization.
Thor AD; Eng C; Devries S; Paterakos M; Watkin WG; Edgerton S; Moore DH; Etzell J; Waldman FM
Hum Pathol; 2002 Jun; 33(6):628-31. PubMed ID: 12152162
[TBL] [Abstract][Full Text] [Related]
58. Genetic abnormalities associated with nodal metastasis in head and neck cancer.
Wreesmann VB; Wang D; Goberdhan A; Prasad M; Ngai I; Schnaser EA; Sacks PG; Singh B
Head Neck; 2004 Jan; 26(1):10-5. PubMed ID: 14724901
[TBL] [Abstract][Full Text] [Related]
59. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
60. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer.
Hergueta-Redondo M; Sarrio D; Molina-Crespo Á; Vicario R; Bernadó-Morales C; Martínez L; Rojo-Sebastián A; Serra-Musach J; Mota A; Martínez-Ramírez Á; Castilla MÁ; González-Martin A; Pernas S; Cano A; Cortes J; Nuciforo PG; Peg V; Palacios J; Pujana MÁ; Arribas J; Moreno-Bueno G
Oncotarget; 2016 Aug; 7(35):56295-56308. PubMed ID: 27462779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
